Shariat SF - Search Results

1

Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.

Chun FK, Briganti A, Shariat SF, Graefen M, Montorsi F, Erbersdobler A, Steuber T, Salonia A, Currlin E, Scattoni V, Friedrich MG, Schlomm T, Haese A, Michl U, Colombo R, Heinzer H, Valiquette L, Rigatti P, Roehrborn CG, Huland H, Karakiewicz PI. Chun FK, et al. Among authors: shariat sf. BJU Int. 2006 Aug;98(2):329-34. doi: 10.1111/j.1464-410X.2006.06262.x. BJU Int. 2006. PMID: 16879673

2

Prostate specific antigen density of the transition zone for early detection of prostate cancer.

Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M. Djavan B, et al. J Urol. 1998 Aug;160(2):411-8; discussion 418-9. J Urol. 1998. PMID: 9679889

3

Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial.

Djavan B, Shariat S, Fakhari M, Ghawidel K, Seitz C, Partin AW, Roehrborn CG, Marberger M. Djavan B, et al. Urology. 1999 Feb;53(2):251-9. doi: 10.1016/s0090-4295(98)00538-x. Urology. 1999. PMID: 9933035 Clinical Trial.

4

Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia.

Djavan B, Roehrborn CG, Shariat S, Ghawidel K, Marberger M. Djavan B, et al. J Urol. 1999 Jan;161(1):139-43. J Urol. 1999. PMID: 10037386 Clinical Trial.

5

Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?

Djavan B, Shariat S, Ghawidel K, Güven-Marberger K, Remzi M, Kovarik J, Hoerl WH, Marberger M. Djavan B, et al. Urology. 1999 Jun;53(6):1169-74. doi: 10.1016/s0090-4295(99)00010-2. Urology. 1999. PMID: 10367847 Clinical Trial.

6

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Shariat SF, et al. Urology. 2001 Dec;58(6):1008-15. doi: 10.1016/s0090-4295(01)01405-4. Urology. 2001. PMID: 11744478

7

Biochemical staging of prostate cancer.

Canto EI, Shariat SF, Slawin KM. Canto EI, et al. Among authors: shariat sf. Urol Clin North Am. 2003 May;30(2):263-77. doi: 10.1016/s0094-0143(02)00183-0. Urol Clin North Am. 2003. PMID: 12735503 Review.

8

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

Kattan MW, Shariat SF, Andrews B, Zhu K, Canto E, Matsumoto K, Muramoto M, Scardino PT, Ohori M, Wheeler TM, Slawin KM. Kattan MW, et al. Among authors: shariat sf. J Clin Oncol. 2003 Oct 1;21(19):3573-9. doi: 10.1200/JCO.2003.12.037. Epub 2003 Aug 11. J Clin Oncol. 2003. PMID: 12913106 Clinical Trial.

9

Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.

Shariat SF, Kattan MW, Song W, Bernard D, Gottenger E, Wheeler TM, Slawin KM. Shariat SF, et al. Cancer Res. 2003 Sep 15;63(18):5874-8. Cancer Res. 2003. PMID: 14522912

10

Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Singh H, et al. Among authors: shariat sf. J Urol. 2004 Mar;171(3):1089-92. doi: 10.1097/01.ju.0000112763.74119.d4. J Urol. 2004. PMID: 14767277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,830 results

Search Page